26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

232 Cudic and Stawikowski<br />

in α-hydroxy acid (see Note 7) and activation of aminoalkylphosphonate with a<br />

4-nitrophenethyloxycarbonyl (NPEOC) group.<br />

These protocols were adopted from refs. (35–37),(40), and(41):<br />

Fmoc protection of hydroxyl group:<br />

1. Dissolve �-hydroxy acid (1 eq) in anhydrous pyridine (20 mL) at 0 o C.<br />

2. Add Fmoc-chloroformate (3 eq).<br />

3. Stir reaction mixture for 3 h at 0 o C.<br />

4. Concentrate reaction mixture under vacuum and purify by column chromatography<br />

over silica gel (eluent: DCM/CH3OH/AcOH=9/0.9/0.1).<br />

Aminoalkylphosphonate activation:<br />

1. Add 1-(N-benzyloxycarbonyl-amino)-alkylphosphonate (1 eq) to aqueous KOH<br />

(5 eq) at room temperature. Monitor reaction by TLC.<br />

2. Wash reaction mixture with diethyl ether.<br />

3. Acidify water phase with concentrated HCl to pH 2 and then extract with EtOAc<br />

(3x).<br />

4. Dry organic phase over MgSO4, filter, and concentrate under vacuum.<br />

5. Dissolve concentrated residue in EtOH and hydrogenate in the presence of 10%<br />

Pd/C catalyst.<br />

6. Upon completion of reaction, filter the mixture through celite, wash catalyst with<br />

MeOH, and concentrate filtrate under vacuum.<br />

7. Dissolve obtained material in H2O.<br />

8. Add Na2CO3 (1.1 eq) and 4-nitrophenylethyl chloroformate (1.1 eq) dissolved in<br />

dioxane.<br />

9. Monitor reaction by TLC.<br />

10. Upon completion of the reaction wash the mixture with diethyl ether, acidify with<br />

concentrated HCl to pH 2 and extract with EtOAc (3x).<br />

11. Dry organic phase over Mg SO4, filter, and concentrate under vacuum.<br />

This protocol was adopted from refs. (35–37).<br />

1. Place resin in dry reaction vessel.<br />

2. Synthesize the desired peptide sequence using standard Fmoc chemistry.<br />

3. Couple α-O-Fmoc–protected hydroxyl acid using HBTU/HOBt or PyBroP<br />

protocol.<br />

4. Remove the Fmoc-protecting group by agitating the resin with 30% piperidine in<br />

NMP (25 mL/mmol, 3 × 10 min).<br />

5. Wash resin with NMP (25 mL/mmol, 5 × 2 min) and diethyl ether<br />

(25 mL/mmol, 5 × 2 min) and dry overnight under vacuum in the presence of<br />

P2O5.<br />

6. Suspend NPEOC-aa-�(HO-P(=O)-OMe) (1 eq) and NMP (1 eq) in anhydrous<br />

THF, then add tris(4-chlorophanyl)phosphine (1 eq) and DIAD (1 eq).<br />

7. Leave reagent mixture for 5 min and then add it to the resin (see Note 8).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!